Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3SY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,258
Award facts
- Contract value 100% obligated
- $11,257.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $11,257.84, was awarded on January 23, 2026, to AmerisourceBergen Drug Corp for the supply of ACTEMRA ACTPEN 162 mg/0.9 ml auto-injector pens. The contract was funded by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for supplying medical and pharmaceutical products to military healthcare systems. The award is not set aside and represents a firm fixed-price contract with an ultimate completion date of January 26, 2026, to be performed at the awardee's facility in Conshohocken, Pennsylvania. ACTEMRA (tocilizumab) is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other inflammatory conditions, making this a specialized pharmaceutical supply for military medical needs.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of its parent company Cencora, Inc., which collectively serves as a critical pharmaceutical distributor for federal agencies. The IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG3SY?
SPE2DR26FG3SY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FG3SY worth?
The government has obligated $11,258 on SPE2DR26FG3SY.
Is contract SPE2DR26FG3SY an order under another contract?
Yes. SPE2DR26FG3SY is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3SY competed?
The extent of competition for SPE2DR26FG3SY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award